In the Vinony graph
Gilead Sciences appears in Vinony's S&P 500 Companies collection — one of 527 entries.
Within Vinony's link graph, Gilead Sciences is referenced by 1,030 other articles, and connects out to tenofovir alafenamide, tenofovir disoproxil and HIV/AIDS.
It is catalogued under topics including 1987 establishments in California, 1992 initial public offerings and American companies established in 1987.
Its subject is documented across 30 Wikipedia language editions.
Key facts
- Company type
- Public
- Traded as
- Nasdaq : GILD Nasdaq-100 component S&P 100 component S&P 500 component
- Industry
- Pharmaceutics Biotechnology
- Founded
- June 22, 1987 ; 38 years ago ( 1987-06-22 )
- Founder
- Michael L. Riordan
- Headquarters
- Foster City, California , United States
- Area served
- Worldwide
- Key people
- Daniel O'Day ( chairman and CEO ) Andrew Dickinson ( CFO ) Tomáš Cihlář ( vice president , and senior director, Biology)
- Products
- AmBisome Atripla Biktarvy Complera Cayston Descovy Emtriva Epclusa Genvoya Harvoni Hepcludex Hepsera Letairis Lexiscan Livdelzi Macugen Odefsey Ranexa Sovaldi Stribild Sunlenca Tamiflu Truvada Tybost Veklury Vemlidy Viread Vosevi Yescarta Yeztugo Zydelig
- Revenue
- US$ 29.44 billion (2025)
- Operating income
- US$10.02 billion (2025)
- Net income
- US$8.510 billion (2025)
- Total assets
- US$59.02 billion (2025)
- Total equity
- US$22.70 billion (2025)
- Number of employees
- 17,000 (2025)
- Website
- gilead .com
via Wikipedia infobox
Company
GILD- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
- Jurisdiction
- US-DE
- Headquarters
- WILMINGTON, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1987
- Location
- Foster City, United States
- Status
- Active
GRID grid.418227.a · ISNI 0000 0004 0402 1634
Wikidata facts
- Instance of
- pharmaceutical company
- Part of
- S&P 100
- Official name
- Gilead Sciences, Inc.
- Country
- United States
- Headquarters
- Foster City
- Owned by
- The Vanguard Group
- Industry
- pharmaceutical industry
- Employees
- 11800
- Revenue
- 27281000000
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- www.gilead.com
- Image
- 333 Lakeside Drive.jpg
Show 9 more facts
- topic's main category
- Category:Gilead Sciences
- Commons category
- Gilead Sciences
- inception
- 1987-06-00
- total assets
- 61627000000
- net profit
- 4592000000
- market capitalization
- 66400000000
- total equity
- 19113000000
- operating income
- 7330000000
- social media followers
- 5890
Sources (13)
via Wikidata · CC0
Article · Italiano
La Gilead Sciences è un'azienda statunitense di biofarmaceutica attiva nell'ambito della ricerca, sviluppo e commercializzazione di farmaci. La società si concentra principalmente sulla produzione di farmaci antivirali utilizzati nel trattamento dell'HIV, dell'epatite B, dell'epatite C e dell'influenza, tra cui Harvoni, Sovaldi e Remdesivir. Fondata nel 1987 e con sede a Foster City in California, la Gilead è membro del NASDAQ Biotechnology Index e dell'indice S&P 500.
Abstract from DBpedia / Wikipedia · CC BY-SA